United Kingdom· GB-APID-45343611000001106
Lumykras 240mg tablets
A sotorasib product containing sotorasib, registered in United Kingdom by Amgen Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sotorasib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01XX73 (sotorasib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Sotorasib · ATC L01XX73
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sotorasib
- Manufacturer
- Amgen Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XX73
- ATC class
- Sotorasib
- Defined daily dose
- 0.96 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin8715131027025
- gtin08715131027025
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sotorasib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLUMYKRASOrifarm Oy
- CzechiaLUMYKRASAmgen Europe B.V., Breda
- United StatesLUMAKRASAmgen Inc
- IrelandLUMYKRAS 120 mg film-coated tabletsAmgen Europe B.V.,
- SpainLUMYKRAS 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAmgen Europe B.V.
- IcelandLumykrasAmgen Europe B.V.*
- NetherlandsLumykras 120 mg, filmomhulde tabletAmgen Europe B.V.
- PolandLumykrasAmgen Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Lumykras
- Norway · Lumykras
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a908ca46-c9c7-48f7-ac83-92120f4739f2 GET /v1/drugs/a908ca46-c9c7-48f7-ac83-92120f4739f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45343611000001106",
"desc": "Lumykras 240mg tablets (Amgen Ltd)",
"form": "Oral tablet",
"vpid": "45354811000001105",
"source": "dmd",
"vtm_id": "1162510009",
"strength": "240 mg",
"substance": "Sotorasib",
"ingredient": "Sotorasib",
"supplier_code": "3303701000001100"
}See everything about sotorasib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.